Auro Vaccines IP estate
Auro Vaccines LLC was founded on and continues to build a substantial intellectual property estate that currently includes:
- U.S. and international patents and patent applications to the original breakthrough discoveries by Wyeth and other third parties which have been licensed or sublicensed to Auro Vaccines
- U.S. and international patents and patent applications to subsequent breakthrough discoveries developed and owned by Auro Vaccines
The IP estate includes U.S. and international patents and patent applications claiming first-in-class and best-in-class prophylactic and therapeutic vaccines utilizing:
- The PBS Vax™ prime/boost platform
- The VesiculoVax™ platform, both as independent vaccines and as a boost
- Attenuated VSV and Isfahan viral vectors
- Disease-specific constructs
Auro Vaccines also has additional extensive experience and know-how supporting its vaccine programs:
- Licensed from Pfizer
- Developed by Auro Vaccines